Get the Stockscreener App
2.94
2.44%
0.07
After Hours:
2.94
Black Diamond Therapeutics Inc stock is traded at $2.94, with a volume of 600.63K.
It is up +2.44% in the last 24 hours and up +7.69% over the past month.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
See More
Previous Close:
$2.87
Open:
$2.89
24h Volume:
600.63K
Relative Volume:
0.59
Market Cap:
$167.39M
Revenue:
-
Net Income/Loss:
$-82.44M
P/E Ratio:
-1.5638
EPS:
-1.88
Net Cash Flow:
$-66.75M
1W Performance:
+6.91%
1M Performance:
+7.69%
6M Performance:
+58.06%
1Y Performance:
-47.31%
1-Day Range:
$2.87
$3.01
1-Week Range:
$2.69
$3.01
52-Week Range:
$1.195
$6.33
Black Diamond Therapeutics Inc Stock (BDTX) Company Profile
Name
Black Diamond Therapeutics Inc
Sector
Industry
Phone
617-417-5868
Address
ONE MAIN STREET, 14TH FLOOR, CAMBRIDGE, MA
Compare BDTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDTX
Black Diamond Therapeutics Inc
|
2.94 | 163.40M | 0 | -82.44M | -66.75M | -1.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Black Diamond Therapeutics Inc Stock (BDTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-04-25 | Initiated | Guggenheim | Buy |
| Jul-01-25 | Resumed | Raymond James | Outperform |
| Jul-31-24 | Initiated | Raymond James | Outperform |
| Jul-14-23 | Initiated | Piper Sandler | Overweight |
| Jun-30-23 | Upgrade | Stifel | Hold → Buy |
| Jun-28-23 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Jun-27-23 | Upgrade | Wedbush | Neutral → Outperform |
| Mar-29-22 | Downgrade | Wedbush | Outperform → Neutral |
| Mar-22-22 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Sep-30-21 | Initiated | Stifel | Hold |
| Jan-07-21 | Initiated | Wedbush | Outperform |
| Nov-24-20 | Initiated | Berenberg | Buy |
| May-04-20 | Initiated | H.C. Wainwright | Buy |
| Feb-24-20 | Initiated | Canaccord Genuity | Buy |
| Feb-24-20 | Initiated | Cowen | Outperform |
| Feb-24-20 | Initiated | JP Morgan | Overweight |
| Feb-24-20 | Initiated | Jefferies | Buy |
View All
Black Diamond Therapeutics Inc Stock (BDTX) Latest News
Detecting price anomalies in Black Diamond Therapeutics Inc. with AIJuly 2025 Levels & Low Risk High Reward Trade Ideas - Newser
Live market analysis of Black Diamond Therapeutics Inc.Trade Risk Report & Target Return Focused Stock Picks - Newser
Black Diamond Therapeutics Inc. stock prediction for this week2025 Institutional Moves & Daily Stock Momentum Reports - Newser
Can Black Diamond Therapeutics Inc. reach all time highs this yearTrade Entry Report & Verified Momentum Watchlists - خودرو بانک
Price Action: What is Black Diamond Therapeutics Inc.’s book value per shareJuly 2025 Catalysts & Safe Entry Trade Signal Reports - خودرو بانک
Can technical indicators confirm Black Diamond Therapeutics Inc.’s reversalJuly 2025 Analyst Calls & Daily Technical Stock Forecast Reports - Newser
Is Black Diamond Therapeutics Inc. stock reversal real or fakeShare Buyback & AI Powered Market Entry Ideas - Newser
Black Diamond Therapeutics Inc. stock trend forecastJuly 2025 Sentiment & Stock Market Timing Techniques - Newser
Is Black Diamond Therapeutics Inc. stock undervalued right now2025 Technical Overview & Real-Time Buy Zone Alerts - خودرو بانک
BDTX Stock Surges 51.1% in Six Months: Is There More Room for Growth? - TradingView
Will Black Diamond Therapeutics Inc. continue its uptrendQuarterly Profit Summary & Expert Verified Movement Alerts - Newser
What’s next for Black Diamond Therapeutics Inc. stock priceOptions Play & Safe Capital Investment Plans - Newser
Is Black Diamond Therapeutics Inc. benefiting from interest rate changesQuarterly Earnings Report & Verified High Yield Trade Plans - خودرو بانک
Is Black Diamond Therapeutics Inc. stock entering bullish territory2025 Support & Resistance & Advanced Technical Signal Analysis - Newser
Multi factor analysis applied to Black Diamond Therapeutics Inc.July 2025 Levels & High Accuracy Buy Signal Tips - Newser
Full technical analysis of Black Diamond Therapeutics Inc. stockQuarterly Portfolio Report & Daily Volume Surge Signals - Newser
Black Diamond Therapeutics Inc. stock retracement – recovery analysisGap Down & Verified Momentum Stock Watchlist - Newser
Is Black Diamond Therapeutics Inc. stock a good pick for beginnersJuly 2025 Final Week & Weekly Watchlist for Consistent Profits - خودرو بانک
Black Diamond Therapeutics stock initiated with Buy rating at Guggenheim By Investing.com - Investing.com Canada
Is the Recent Pipeline Progress on its NSCLC Drug Enough for BDTX? - sharewise.com
Guggenheim Initiates Coverage on BDTX with a 'Buy' Rating | BDTX Stock News - GuruFocus
Black Diamond Therapeutics Inc. stock trendline breakdownEarnings Recap Report & Verified Chart Pattern Signals - Newser
Detecting support and resistance levels for Black Diamond Therapeutics Inc.Market Performance Recap & Capital Efficiency Focused Ideas - Newser
What dividend growth rate does Black Diamond Therapeutics Inc. offerJuly 2025 Update & Advanced Swing Trade Entry Alerts - خودرو بانک
What Fibonacci levels say about Black Diamond Therapeutics Inc. reboundWeekly Earnings Recap & Risk Adjusted Buy/Sell Alerts - Newser
How to use a screener to detect Black Diamond Therapeutics Inc. breakouts2025 Earnings Impact & Low Volatility Stock Recommendations - Newser
Will Black Diamond Therapeutics Inc. stock go up soonWall Street Watch & Low Drawdown Trading Strategies - Newser
What is Black Diamond Therapeutics Inc.’s book value per shareWeekly Stock Summary & Weekly Watchlist for Hot Stocks - خودرو بانک
Can Black Diamond Therapeutics Inc. recover in the next quarterWeekly Trend Report & Free Growth Oriented Trading Recommendations - Newser
Key resistance and support levels for Black Diamond Therapeutics Inc.2025 Historical Comparison & Accurate Intraday Trade Tips - Newser
Is Black Diamond Therapeutics Inc. still worth holding after the dipRate Hike & Low Drawdown Investment Strategies - Newser
Is it time to cut losses on Black Diamond Therapeutics Inc.Trade Volume Report & Low Risk Growth Stock Ideas - Newser
Black Diamond Therapeutics Inc. stock outlook for YEARJuly 2025 Drop Watch & Community Shared Stock Ideas - Newser
Black Diamond Therapeutics Inc. stock trend outlook and recovery path2025 Growth vs Value & Low Risk Profit Maximizing Plans - Newser
Forecasting Black Diamond Therapeutics Inc. price range with options data2025 Trading Recap & Precise Trade Entry Recommendations - Newser
Multi asset correlation models including Black Diamond Therapeutics Inc.Weekly Profit Report & Growth Focused Investment Plans - Newser
Black Diamond Therapeutics Inc Stock (BDTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):